Evaluation of Therapy for Lymphoma
- 31 July 2005
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 35 (3) , 186-196
- https://doi.org/10.1053/j.semnuclmed.2005.02.004
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- FDG-PET is Superior to Gallium Scintigraphy in Staging and More Sensitive in the Follow-up of Patients withde novoHodgkin Lymphoma: A Blinded ComparisonLeukemia & Lymphoma, 2004
- 18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non‐Hodgkin's lymphomaBritish Journal of Haematology, 2003
- PET scan imaging in oncologyEuropean Journal Of Cancer, 2003
- 18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patientsNuclear Medicine Communications, 2002
- F-18 FDG Versus Ga-67 for Detecting Splenic Involvement in Hodgkin’s DiseaseClinical Nuclear Medicine, 2002
- Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphomaBone Marrow Transplantation, 2002
- Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?European Journal Of Cancer, 2000
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal Of Cancer, 1999
- Vortäuschung eines mediastinalen Non-Hodgkin-Lymphomrezidivs durch diffuse Thymushyperplasie im18F-FDG-PETRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995